Terapia-Ranbaxy Looks To Outperform Market

July 2007 | Company Finance Alert

Propelled by rapid introduction of new products, the Romanian subsidiary of Indian generics giant Ranbaxy - Terapia-Ranbaxy - is looking to double turnover by 2010. Given that revenue topped US$110mn in 2006, the company needs to post 19% year-on-year growth, outpacing competitors by four percentage points. BMI is very confident that Terapia-Ranbaxy can achieve this goal given its performance last year and the firm's strategy of organic growth in one Central and Eastern Europe's most attractive pharmaceutical

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.